News

Novo Nordisk will invest $2 billion starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Hillerød, Denmark to support its future portfolio in serious chronic diseases. The facility will create additional production capacity and increase...

SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. SK pharmteco...

Women’s health has often been overlooked despite involving 50% of the population. However, there is growing recognition of the differences in health needs and outcomes between men and women. Scientific breakthroughs, new technologies, and policies provide unique opportunities to...

Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a...

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets. The LPS in vivo model supports...

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, will share a first look at industry research at the DIA Global Annual Meeting 2023. CluePoints will host an exclusive opportunity for RBQM...

To gain a competitive advantage, organizations are proactively overhauling their digital transformation strategies. It has become evident that traditional paper-based operations and fragmented data collection methods limit their ability to adapt and thrive in the constantly shifting market. The...